NCT04144673 is a NA clinical trial of Silver Hydrosol in Healthy, sponsored by Natural Immunogenics Corp..

Who is sponsoring NCT04144673?

NCT04144673 is sponsored by Natural Immunogenics Corp..

What drugs are being tested in NCT04144673?

Interventions in NCT04144673: Silver Hydrosol, Placebo.

Is NCT04144673 still recruiting?

NCT04144673 is currently completed. Last updated 23 April 2021.

Last reviewed 2021-04-23 · How we verify

NCT04144673

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Study Investigating the Safety and Efficacy of Bio-Active Silver Hydrosol™ in Providing Immune Support

Completed NA Last updated 23 April 2021

What this trial tests

NA trial testing Silver Hydrosol in Healthy in 60 participants. Completed in 1 June 2020.

Timeline

14 November 2019

Primary endpoint
1 June 2020

1 June 2020

Quick facts

Lead sponsor	Natural Immunogenics Corp.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	other
Enrollment	60
Start date	14 November 2019
Primary completion	1 June 2020
Estimated completion	1 June 2020
Sites	1 location across Canada

Drugs / interventions tested

Silver Hydrosol
Placebo

Conditions studied

Healthy — all drugs for Healthy →

Sponsor

Natural Immunogenics Corp.

Who can join

Adults 19 to 65, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to investigate the ability of Bio-Active Silver Hydrosol™ in providing immune support in healthy adult males and females participating in intense aerobic exercise. Sixty eligible participants are planned to be randomized into either the investigational product or treatments arms and will consume the study product for 60 days (check-in visit on day 28). Questionnaires will be completed and blood and saliva samples will be collected to measure the endpoints.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04144673 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Natural Immunogenics Corp.
Last refreshed: 23 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04144673.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing